Combinations of a PI3K inhibitor and a MEK inhibitor

Details for Australian Patent Application No. 2010314287 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Belvin, Marcia; Chan, Iris T.; Friedman, Lori; Hoeflich, Klaus P.; Prescott, John; Wallin, Jeffrey

Agent Griffith Hack

Pub. Number AU-A-2010314287

PCT Pub. Number WO2011/054620

Priority 61/250,852 12.10.09 US

Filing date 11 October 2010

Wipo publication date 12 May 2011

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/5377 (2006.01)

A61K 35/00 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/054620 Priority application(s): WO2011/054620

12 July 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 Jun 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010314292-Method and system for adapting a session timeout period

2010314281-A nanohole array biosensor